<DOC>
	<DOCNO>NCT01278914</DOCNO>
	<brief_summary>PRIMARY OBJECTIVES : Determination safety toxicity vaccination mRNA transfected DC ( base blood sample , adverse event ) . SECONDARY OBJECTIVES : Determine immunological response vaccine ( induction specific T-cell response ) assessment tumour response .</brief_summary>
	<brief_title>Trial Vaccine Therapy With mRNA- Transfected Dendritic Cells Patients With Androgen Resistant Metastatic Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Must least 45 year age . Must histologically confirm adenocarcinoma prostate . Must evidence disease progression LHRH agonist , orchiectomy , without antiandrogen advanced prostate cancer . All patient maintain hormone regimen throughout protocol receiving time entry recent progression . Increasing PSA three subsequent analysis . Must ambulatory ECOG performance score &lt; 2 Lab.values follow : ANC ( 1.5 x 109/L ; platelet ( 100 x 109/L , Hb ( 9 g/dL ( ( 5.6 mmol/L ) . Creatinine ( 140 Âµmol/L ( 1.6 mg/dL ) ; borderline , creatinine clearance ( 40 mL/min , Bilirubin &lt; 20 % upper limit normal , ASAT ALAT ( 2.5 upper limit normal . Albumin ( 2.5 g/L ) . Prior radiotherapy : minimum 4 week ( 8 week case extensive prior radiotherapy ) must elapse end prior radiotherapy entry protocol . Prior chemotherapy : minimum 4 week must elapse prior entry study . If patient receive strontium89 alpharadin , least three month must elapse prior entry study . Informed consent expect cooperation patient treatment followup must obtain document accord ICHGCP Guidelines . History prior malignancy prostate cancer , clinically evident within 24 month precede enrolment study , except curativelytreated basal cell squamous cell carcinoma skin . Active infection require antibiotic therapy . Significant cardiac medical illness would limit activity survival , severe congestive heart failure , unstable angina , serious cardiac arrhythmia . Autoimmune disease treat steroid ( ) History asthma , anaphylaxis serious adverse reaction vaccine . History immunodeficiency autoimmune disease rheumatoid arthritis , systemic lupus erythematosus , scleroderma , polymyositis/dermatomyositis , juvenile onset insulin dependent diabetes , vasculitic syndrome . Chemotherapy potentially immunesuppressive therapy administer within 4 week prior vaccination . Impending untreated spinal cord compression urinary outlet obstruction . Any reason , opinion investigator , patient participate .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>